OPSM Australia & New Zealand Webinars targeted at Optometrists on Moderate to Severe Dry Eye Disease
Date: 5/10/2021 (AEDT)
Venue: Live Webinar - Zoom
Provider: Andrew Cooney - Novartis Pharmaceuticals Australia Pty Ltd
Contact: Andrew Cooney, [E] andrew.cooney@novartis.com, [P] 0437 797 667
To Register: https://www.medhub.com.au/en/node/10971?hash=b68356e8c1722af7f88992f057cd92ad6f19868c274ae7160b884f09db3537e2
Learning Objectives
- Understand the diagnosis, progression and management of patients with Moderate to Severe Dry Eye Disease including being aware of an overview of current & new treatment options
- Know when moderate to Severe Dry Eye treatments are indicated and introduced within Dry Eye Disease patient journey
- Understand that one approach does not fit all in the management of these Moderate to Severe Dry eye disease patients, as we are dealing with very hypersensitive patients
- Understand the difference between Ocular medication Side Effects Vs Drug Formulation reactions of Patients with Dry Eye Disease
- Not forget the basics about Ocular Lubricants in combination with the Prescribed Interventions within the management of Moderate to Severe Dry Eye Disease Patients
Max CPD hours awarded: 1.5
Session Information
Name |
---|
Diagnosis & Management of the Moderate-Severe Dry Eye Patient |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
1.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
1.5 |